Trial Profile
Patients with bone marrow oedema-associated knee pain, randomised to zolendronic acid or placebo, assessed by the amount of knee pain after three and twelve months.
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Acronyms ZAP
- 05 Mar 2012 New trial record